These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12169042)

  • 1. A pharmacokinetic profile of desloratadine in healthy adults, including elderly.
    Affrime M; Gupta S; Banfield C; Cohen A
    Clin Pharmacokinet; 2002; 41 Suppl 1():13-9. PubMed ID: 12169042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine.
    Affrime M; Banfield C; Gupta S; Cohen A; Boutros T; Thonoor M; Cayen M
    Clin Pharmacokinet; 2002; 41 Suppl 1():21-8. PubMed ID: 12169043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desloratadine demonstrates dose proportionality in healthy adults after single doses.
    Gupta S; Banfield C; Affrime M; Marco A; Cayen M; Herron J; Padhi D
    Clin Pharmacokinet; 2002; 41 Suppl 1():1-6. PubMed ID: 12169040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole.
    Banfield C; Herron J; Keung A; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():37-44. PubMed ID: 12169045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of clinically relevant interaction between desloratadine and erythromycin.
    Banfield C; Hunt T; Reyderman L; Statkevich P; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():29-35. PubMed ID: 12169044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
    Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB
    Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability of desloratadine is unaffected by food.
    Gupta S; Banfield C; Affrime M; Marbury T; Padhi D; Glue P
    Clin Pharmacokinet; 2002; 41 Suppl 1():7-12. PubMed ID: 12169041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
    Banfield C; Gupta S; Marino M; Lim J; Affrime M
    Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment.
    Gupta SK; Kantesaria B; Wang Z
    J Clin Pharmacol; 2007 Oct; 47(10):1283-91. PubMed ID: 17906161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S; Banfield C; Kantesaria B; Marino M; Clement R; Affrime M; Batra V
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.
    Solans A; Carbó ML; Peña J; Nadal T; Izquierdo I; Merlos M
    Clin Ther; 2007 May; 29(5):900-908. PubMed ID: 17697908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers.
    Gupta S; Banfield C; Kantesaria B; Flannery B; Herron J
    J Clin Pharmacol; 2004 Nov; 44(11):1252-9. PubMed ID: 15496643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
    Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
    Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males.
    Hakooz N; Salem II
    Biopharm Drug Dispos; 2012 Jan; 33(1):15-21. PubMed ID: 22271705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacologic profile of desloratadine: a review.
    Henz BM
    Allergy; 2001; 56 Suppl 65():7-13. PubMed ID: 11243504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on determination of desloratadine in human serum and its pharmacokinetics by HPLC/MS].
    Lu XY; Sheng-Tu JZ; Chen ZG; Huang MZ; Zhou HL; Zheng GG
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 34(4):372-4. PubMed ID: 16059990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.